ArticleCancer immunology, immunotherapy : CII2019

Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1).

Despoina Koumantou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.